MONEY CONCEPTS CAPITAL CORP
Position in GILD — Gilead Sciences, Inc.
CIK 716851
PALM BEACH GARDENS, FL
Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$7,278,952
-$3,850,718 QoQ
Shares Held
57,614
-27.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#497
of 2,266 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONEY CONCEPTS CAPITAL CORP holds $69,606,072 across 12 Drug Manufacturers - General names. GILD ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,841 | $16,601,312 | |
| 2 | JNJ |
Johnson & Johnson
|
48,780 | $12,388,656 | |
| 3 | ABBV |
AbbVie Inc.
|
38,565 | $9,704,496 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
57,614 | $7,278,952 | |
| 5 | NVO |
Novo Nordisk A S
|
129,801 | $6,222,659 | |
| 6 | PFE |
Pfizer Inc
|
239,692 | $5,771,783 | |
| 7 | MRK |
Merck & Co., Inc.
|
32,575 | $4,185,887 | |
| 8 | AMGN |
Amgen Inc
|
9,402 | $3,404,652 |
All Filings in GILD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,278,952 | 57,614 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $11,129,670 | 79,857 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $10,568,527 | 86,105 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $10,015,641 | 90,231 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $10,165,226 | 91,686 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,074,975 | 89,915 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $8,362,995 | 90,538 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $7,907,285 | 94,314 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $6,606,182 | 96,286 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $6,939,705 | 94,740 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $8,314,704 | 102,638 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $7,846,667 | 104,706 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $7,684,957 | 99,714 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $19,675,588 | 237,141 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $24,505,367 | 285,444 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,707,004 | 287,032 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $6,293,123 | 101,814 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $6,135,418 | 103,203 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,599,144 | 104,657 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $6,454,339 | 99,866 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,600,576 | 27,473 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||